1,176
Views
3
CrossRef citations to date
0
Altmetric
Articles

Haloperidol, but not olanzapine, may affect expression of PER1 and CRY1 genes in human glioblastoma cell line

, , , , , , , & show all
Pages 865-871 | Received 09 Jun 2016, Accepted 13 Jun 2016, Published online: 01 Jul 2016

References

  • Aravagiri M, Teper Y, Marder SR. 1999. Pharmacokinetics and tissue distribution of olanzapine in rats. Biopharm Drug Dispos [Internet]. [cited 2016 Jun 7]. 20:369–377. Available from: http://dx.doi.org/10.1002/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-610.1002/(ISSN)1099-081X
  • Buhusi CV, Meck WH. 2007. Effect of clozapine on interval timing and working memory for time in the peak-interval procedure with gaps. Behav Processes [Internet]. [cited 2016 Jun 7]. 74:159–167. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1849977/10.1016/j.beproc.2006.10.004
  • Coogan AN, Papachatzaki MM, Clemens C, Baird A, Donev RM, Joosten J, Zachariou V, Thome J. 2011. Haloperidol alters circadian clock gene product expression in the mouse brain. World J Biol Psychiatry. 12:638–644.10.3109/15622975.2010.543149
  • Dashti HS, Smith CE, Lee Y-C, Parnell LD, Lai C-Q, Arnett DK, Ordovás JM, Garaulet M. 2014. CRY1 circadian gene variant interacts with carbohydrate intake for insulin resistance in two independent populations: Mediterranean and North American. Chronobiol Int [Internet]. [cited 2016 June 7]. 31:660–667. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041822/10.3109/07420528.2014.886587
  • De Hert MA, van Winkel R, Van Eyck D, Hanssens L, Wampers M, Scheen A, Peuskens J. 2006. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophr Res. [updated 2015 Nov 19; cited 2016 June 7]. 83:87–93. Available from: http://www.schres-journal.com/article/S092099640600003X/fulltext10.1016/j.schres.2005.12.855
  • Duffield GE, Best JD, Meurers BH, Bittner A, Loros JJ, Dunlap JC. 2002. Circadian programs of transcriptional activation, signaling, and protein turnover revealed by microarray analysis of mammalian cells. Curr Biol. 12:551–557.10.1016/S0960-9822(02)00765-0
  • Gallego M, Virshup DM. 2007. Post-translational modifications regulate the ticking of the circadian clock. Nat Rev Mol Cell Biol. 8:139–148.10.1038/nrm2106
  • Gustafson CL, Partch CL. 2015. Emerging models for the molecular basis of mammalian circadian timing. Biochemistry. 54:134–149.10.1021/bi500731f
  • Hiemke C, Baumann P, Bergemann N, Conca a., Dietmaier O, Egberts K, Fric M, Gerlach M, Greiner C, Gründer G, et al. 2011. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry. 44:195–235.
  • Kishi T, Kitajima T, Ikeda M, Yamanouchi Y, Kinoshita Y, Kawashima K, Okochi T, Okumura T, Tsunoka T, Inada T, et al. 2009. Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population. Eur Arch Psychiatry Clin Neurosci. 259:293–297.10.1007/s00406-009-0869-4
  • Köles L, Kató E, Hanuska A, Zádori Z, Al-Khrasani M, Zelles T, Rubini P, Illes P. 2015. Modulation of excitatory neurotransmission by neuronal/glial signalling molecules: interplay between purinergic and glutamatergic systems. Purinergic Signal [Internet]. [cited 2016 June 7]. 1–24. doi:10.1007/s11302-015-9480-5.
  • Kornhuber J, Schultz A, Wiltfang J, Meineke I, Gleiter CH, Zöchling R, Boissl K-W, Leblhuber F, Riederer P. 1999. Persistence of haloperidol in human brain tissue. Am J Psychiatry [Internet]. [cited 2016 Jun 7]. 156:885–890. doi:10.1176/ajp.156.6.885 10.1176/ajp.156.6.885
  • Liu Z, Chu G. 2013. Chronobiology in mammalian health. Mol Biol Rep. 40:2491–2501.10.1007/s11033-012-2330-4
  • Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 25:402–408.10.1006/meth.2001.1262
  • MacDonald CJ, Meck WH. 2005. Differential effects of clozapine and haloperidol on interval timing in the supraseconds range. Psychopharmacology (Berl). 182:232–244.10.1007/s00213-005-0074-8
  • Mansour HA, Talkowski ME, Wood J, Chowdari KV, McClain L, Prasad K, Montrose D, Fagiolini A, Friedman ES, Allen MH, et al. 2009. Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord [Internet]. [cited 2016 June 7]. 11:701–710. doi:10.1111/j.1399-5618.2009.00756.x. 10.1111/bdi.2009.11.issue-7
  • Monti JM, BaHammam AS, Pandi-Perumal SR, Bromundt V, Spence DW, Cardinali DP, Brown GM. 2013. Sleep and circadian rhythm dysregulation in schizophrenia. Prog Neuro-Psychopharmacology Biol Psychiatry [Internet]. [updated 2016 Jan 8; cited 2016 Jun 7]. 43:209–216. Available from: http://www.sciencedirect.com/science/article/pii/S027858461200341710.1016/j.pnpbp.2012.12.021
  • Nolan T, Hands RE, Bustin Sa. 2006. Quantification of mRNA using real-time RT-PCR. Nat Protoc. 1:1559–1582.10.1038/nprot.2006.236
  • Peng ZW, Chen XG, Wei Z. 2007. Cryptochrome1 maybe a candidate gene of schizophrenia. Med Hypotheses. 69:849–851.10.1016/j.mehy.2007.02.003
  • Rosbash M. 1998. Why the rat-1 fibroblast should replace the SCN as the in vitro model of choice. Cell [Internet]. [accessed 2016 Jun 7]. 93:917–919. Available from: http://www.cell.com/article/S0092867400811976/fulltext 10.1016/S0092-8674(00)81197-6
  • Sherman H, Genzer Y, Cohen R, Chapnik N, Madar Z, Froy O. 2012. Timed high-fat diet resets circadian metabolism and prevents obesity. FASEB J. 26:3493–3502.10.1096/fj.12-208868
  • Stahl SM. 2013. Stahl’s essential psychopharmacology neuroscientific basis and practical applications. 4th ed. Cambridge: Cambridge University Press.
  • Viyoch J, Matsunaga N, Yoshida M, To H, Higuchi S, Ohdo S. 2005. Effect of haloperidol on mPer1 gene expression in mouse suprachiasmatic nuclei. J Biol Chem. 280:6309–6315.10.1074/jbc.M411704200
  • Zhang J, Liao G, Liu C, Sun L, Liu Y, Wang Y, Jiang Z, Wang Z. 2011. The association of CLOCK gene T3111C polymorphism and hPER3 gene 54-nucleotide repeat polymorphism with Chinese Han people schizophrenics. Mol Biol Rep. 38:349–354.10.1007/s11033-010-0114-2